Adicet Bio, Inc.
NASDAQ: ACET0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chen Schor
- Employees
- 152
- Headquarters
- Boston, United States
- IPO year
- 2018
- Market cap
- $77.1M
- Website
- https://www.adicetbio.com
Loading ACET…
Loading profile data…Frequently asked questions about ACET
What does Adicet Bio, Inc. (ACET) do?
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve...
Where does ACET trade?
Adicet Bio, Inc. (ACET) trades on the NASDAQ Global Market.
What sector is ACET in?
Adicet Bio, Inc. (ACET) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Adicet Bio, Inc.?
Chen Schor is the chief executive officer of Adicet Bio, Inc. (ACET).
Where is Adicet Bio, Inc. headquartered?
Adicet Bio, Inc. is headquartered in United States.
Does ACET pay a dividend?
Adicet Bio, Inc. (ACET) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACET go public?
Adicet Bio, Inc. (ACET) completed its initial public offering in 2018.